-
EPA Bans TCE, a Solvent Linked to PD
-
Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations
-
Adaptive DBS – a new approach to improve PD symptoms
-
Recently published research on induced pluripotent stem cells by APDA-funded researchers
-
Crexont®: A Newly Approved Parkinson’s Medication
-
Healthy Brains Act Takes Aim at Environmental Causes of Parkinson’s and Other Neurodegenerative Diseases
-
Historic News for the PD Community
-
Understanding levodopa-induced dyskinesias: APDA-funded research published
-
How alpha-synuclein affects brain cell communication: APDA-funded research published
-
A Tribute to Dr. Mahlon DeLong
